Shares of the following companies had unusual moves in U.S. trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York.
Brown & Brown Inc. (BRO) (BRO US) rose 5 percent to $24.52, the highest price since July 14. The insurance and risk management provider reported fourth-quarter profit that beat analysts’ estimates. William Blair & Co. raised the stock’s rating to “outperform” from “market perform.”
Depomed Inc. (DEPO) (DEPO US) gained 5.4 percent to $7.06, the highest price since Aug. 1. The drugmaker said it will get “modest, single-digit royalties” on net product sales of Merck & Co.’s (MRK US) type 2 diabetes Janumet XR until the expiration of the licensed patents.
Dresser-Rand Group Inc. (DRC) (DRC US) rose 6.3 percent, the most since Aug. 29, to $52.32. The maker of equipment for oil and natural gas industries was raised to “buy” from “neutral” at Pritchard Capital Partners LLC, while Barclays Plc. said the share price presents an “opportunity for patient investors.” The stock fell 6.9 percent Feb. 3 after the company cut it forecast for operating income.
Fusion-io Inc. (FIO US) gained 11 percent, the most since Jan. 3, to $24.72. EMC Corp.’s VFCache is unlikely to affect the maker of flash-memory technology’s business in the near term, according to ThinkEquity LLC.
HCA Holdings Inc. (HCA US) advanced 7.3 to $28.40, the highest price since July 22. The largest hospital chain hospital company by revenue reported fourth-quarter profit surged because of an acquisition and said it will pay a one-time dividend of $2 a share.
Humana Inc. (HUM US) fell 5.4 percent to $85.25 for the second-biggest retreat in the Standard & Poor’s 500 Index. The second-largest Medicare provider said 2012 profit will be $7.50 to $7.70 a share. That trailed the average analyst estimate of $8.05, data compiled by Bloomberg show.
Lazard Ltd. (LAZ US) slid 4.2 percent, the most since Dec. 14, to $27.67. The largest independent merger adviser said fourth-quarter profit declined on a decrease in revenue from advising on deals.
Medco Health Solutions Inc. (MHS US) fell the most in the S&P 500, sliding 8.1 percent to $58.47. “Key people” at the Federal Trade Commission are seeking to stop Express Scripts Inc.’s (ESRX US) acquisition of the pharmacy-benefits manager, Reuters reported, citing a source closely watching the deal. Express Scripts fell 4.6 percent to $49.67.
O’Charley’s Inc. (CHUX US) rallied 42 percent, the most since December 2008, to $9.81. Fidelity National Financial Inc. (FNF US), the largest U.S. title insurer, agreed to buy the restaurant owner for about $216 million, or $9.85 a share.
Sohu.com Inc. (SOHU US) fell 15 percent, the most since October 2009, to $53.41. The owner of China’s third-biggest search-engine posted an unexpected 39 percent decline in profit as the company incurred a charge from acquisitions, eroding higher advertising and games sales.
Changyou.com Ltd. (CYOU US), Sohu.com’s games unit, tumbled 13 percent to $25.31.
Sprint Nextel Corp. (S US) rose the second-most in the S&P 500, climbing 6 percent to $2.46. The third-largest U.S. wireless-phone service, scheduled to release its fourth-quarter results on Feb. 8, offers a buying opportunity for investors because earnings during the period “mostly likely” marked the trough, Macquarie Group Ltd. said.
Sysco Corp. (SYY US) fell 3.6 percent, the most since Aug. 15, to $29.79. North America’s largest distributor of food to restaurants, hospitals and schools reported a bigger-than- expected decline in second-quarter gross margin, according to Barclays Plc.
SureWest Communications (SURW US) rallied 45 percent to $22.67 for the biggest increase in the Russell 2000 Index. Consolidated Communications Holdings Inc. (CNSL US) is agreed to buy the operator of an integrated network of communications products for $23 a share.
TiVo Inc. (TIVO US) climbed 2.8 percent to $11.54, the highest price since May 2010. The digital-video recording pioneer may rise to $18 or higher as patent-lawsuit settlements boost income and its digital-recording technology attracts takeover bids, Barron’s reported.
Weyerhaeuser Co. (WY US) declined 2.8 percent, the most since Dec. 12, to $20.70. The U.S. lumber producer and home builder was cut to “sell” from “neutral” at UBS AG, which cited valuations.
Whirlpool Corp. (WHR US) rallied 3 percent to $70.74, the highest price since July 27. The world’s largest maker of household appliances was raised to “buy” from “neutral” at Longbow Research.
Zogenix Inc. (ZGNX US) retreated 8.1 percent, the most since Nov. 9, to $2.51. The specialty pharmaceutical company filed a plan to sell as much as $75 million of securities. Proceeds will be used to help fund the commercialization of its Sumavel DosePro and Zohydro drugs and develop new product candidates.
To contact the editor responsible for this story: Nick Baker at firstname.lastname@example.org